Coherus BioSciences Inc (NASDAQ:CHRS)
| 13.22 Delayed Data As of Jan 18 |  -0.67 / -4.82%Today’s Change | 12.21 Today|||52-Week Range 22.22 | -17.17% Year-to-Date |
Latest CHRS News | Press Releases
No recent news for Coherus BioSciences Inc.
Today’s Trading
| Previous close | 13.90 |
| Today’s open | 14.07 |
| Day’s range | 13.22 - 14.07 |
| Volume | 859,850 |
| Average volume (3 months) | 698,566 |
| Market cap | $1.0B |
Data as of 4:01pm ET, 01/18/2022
Growth & Valuation
| Earnings growth (last year) | +43.64% |
| Earnings growth (this year) | -322.84% |
| Earnings growth (next 5 years) | +3.10% |
| Revenue growth (last year) | +33.63% |
| P/E ratio | NM |
| Price/Sales | 3.05 |
| Price/Book | 3.59 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| REPLReplimune Group Inc | -1.84 | -7.71% |
| RCKTRocket Pharmaceutica... | -1.61 | -8.58% |
| MORMorphoSys AG | -0.33 | -3.89% |
| RGNXRegenxbio Inc | -1.61 | -5.76% |
Data as of 4:01pm ET, 01/18/2022
Financials
| Next reporting date | March 3, 2022 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $475.8M |
| Annual profit (last year) | $132.2M |
| Net profit margin | 27.79% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
